Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy.
J Immunother Cancer. 2020 Oct;8(2):e001191. doi: 10.1136/jitc-2020-001191.
J Immunother Cancer. 2020.
PMID: 33082167
Free PMC article.